Does CEFTAZIDIME Cause Hyperbilirubinaemia? 60 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Hyperbilirubinaemia have been filed in association with CEFTAZIDIME (TAZICEF). This represents 1.9% of all adverse event reports for CEFTAZIDIME.
60
Reports of Hyperbilirubinaemia with CEFTAZIDIME
1.9%
of all CEFTAZIDIME reports
1
Deaths
49
Hospitalizations
How Dangerous Is Hyperbilirubinaemia From CEFTAZIDIME?
Of the 60 reports, 1 (1.7%) resulted in death, 49 (81.7%) required hospitalization, and 25 (41.7%) were considered life-threatening.
Is Hyperbilirubinaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEFTAZIDIME. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does CEFTAZIDIME Cause?
Drug ineffective (518)
Off label use (266)
Condition aggravated (228)
Septic shock (200)
Acute kidney injury (191)
Pyrexia (176)
Endophthalmitis (128)
Multiple organ dysfunction syndrome (124)
Neutropenia (123)
Drug reaction with eosinophilia and systemic symptoms (121)
What Other Drugs Cause Hyperbilirubinaemia?
METHOTREXATE (603)
RIBAVIRIN (560)
VINCRISTINE (479)
CYTARABINE (397)
PEGASPARGASE (349)
ACETAMINOPHEN (330)
CYCLOPHOSPHAMIDE (330)
DEXAMETHASONE (315)
CAPECITABINE (279)
SOFOSBUVIR (260)
Which CEFTAZIDIME Alternatives Have Lower Hyperbilirubinaemia Risk?
CEFTAZIDIME vs CEFTIBUTEN
CEFTAZIDIME vs CEFTOLOZANE\TAZOBACTAM
CEFTAZIDIME vs CEFTRIAXONE
CEFTAZIDIME vs CEFTRIAXONE\CEFTRIAXONE
CEFTAZIDIME vs CEFUROXIME